Genus plc (LSE:GNS) has upgraded its outlook for the financial year ended 30 June 2026 after stronger-than-expected trading, supported by robust growth across its Asian operations, improved cash generation and the contribution from its new Chinese joint venture. The animal genetics specialist said adjusted pre-tax profit is now expected to come in moderately ahead of market consensus at around £98 million.Read More
